U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06832852) titled 'Which Model of Care is the Most Cost-effective in the Treatment of Musculoskeletal Disorders?' on Feb. 11.
Brief Summary: As musculoskeletal disorders (MSKDs) reach epidemic proportions in Canada, access to the public health system for those who suffer from them is increasingly difficult. One of the main barriers is the delays to see a publicly funded health professional. New models of care must therefore be developed to ensure better access. We have previously shown that not all patients with a MSKD need to be closely followed by a health professional as for a large proportion of patients simply educating them is enough to resolve ...